Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
City of Germany’s patient zero says COVID-19 fight not over
2 February 2021Effect of redundant clinical trials from mainland China evaluating statins in patients with coronary artery disease: cross sectional study
2 February 2021Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
Houston Methodist researchers have developed a mathematical model to predict how specific cancers will respond to immunotherapy treatments, thus enhancing chances for successful treatments from a wide variety of cancer-immunotherapy drug combinations. The results were published last month in Nature Biomedical Engineering in collaboration with researchers at MD Anderson Cancer Center.
